Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

REUMAKLINIK FYN, SPECIALLÆGEKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   3.7% 2.7% 1.9% 2.0% 1.5% 1.7% 20.4% 20.4%   Credit score (0-100)   53 62 70 67 76 71 5 5   Credit rating   BBB BBB A A A A B B   Credit limit (kDKK)   0.0 0.0 0.4 0.1 7.2 1.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,428 2,479 2,399 2,018 2,058 2,881 0.0 0.0   EBITDA   642 967 823 547 581 1,067 0.0 0.0   EBIT   642 967 823 486 564 1,036 0.0 0.0   Pre-tax profit (PTP)   593.9 911.7 752.6 486.0 555.0 1,037.9 0.0 0.0   Net earnings   451.2 702.2 577.3 369.0 513.0 809.5 0.0 0.0   Pre-tax profit without non-rec. items   646 964 817 486 555 1,038 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   336 323 258 196 301 271 0.0 0.0   Shareholders equity total   562 816 794 662 875 985 1.0 1.0   Interest-bearing liabilities   1.3 84.2 207 0.0 308 0.0 0.0 0.0   Balance sheet total (assets)   1,058 1,365 1,544 1,098 1,454 1,657 1.0 1.0   Net Debt   -67.0 -762 -666 -555 -12.0 -764 -1.0 -1.0     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,428 2,479 2,399 2,018 2,058 2,881 0.0 0.0   Gross profit growth   11.3% 2.1% -3.2% -15.9% 2.0% 40.0% -100.0% 0.0%   Employees   0 3 2 3 3 2 0 0   Employee growth %   0.0% 0.0% -33.3% 50.0% 0.0% -33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,058 1,365 1,544 1,098 1,454 1,657 1 1   Balance sheet change%   -21.8% 29.0% 13.2% -28.9% 32.4% 14.0% -99.9% 0.0%   Added value   642.2 967.1 823.4 547.0 625.0 1,066.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -52 -12 -65 -123 88 -61 -271 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.4% 39.0% 34.3% 24.1% 27.4% 36.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   54.0% 79.8% 56.7% 36.8% 44.2% 66.7% 0.0% 0.0%   ROI %   89.9% 131.5% 86.4% 58.5% 61.1% 95.2% 0.0% 0.0%   ROE %   84.1% 101.9% 71.7% 50.7% 66.8% 87.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   53.1% 59.8% 51.4% 60.3% 60.2% 59.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -10.4% -78.8% -80.9% -101.5% -2.1% -71.6% 0.0% 0.0%   Gearing %   0.2% 10.3% 26.1% 0.0% 35.2% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.8% 6.4% 4.9% 0.0% 5.8% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   1.4 1.8 1.7 1.9 1.9 2.0 0.0 0.0   Current Ratio   1.4 1.8 1.7 1.9 1.9 2.0 0.0 0.0   Cash and cash equivalent   68.3 846.4 873.2 555.0 320.0 763.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   180.5 453.6 488.4 407.0 516.0 659.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 322 412 182 208 533 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 322 412 182 194 533 0 0   EBIT / employee   0 322 412 162 188 518 0 0   Net earnings / employee   0 234 289 123 171 405 0 0